Skip to main content

Table 2 Dosimetric parameters (N = 64)

From: French multicentre clinical evaluation of helical TomoTherapy® for anal cancer in a cohort of 64 consecutive patients

 

Mean

(SD)

Planning Target Volume 1

  

 Dose, Gy

44.04

(5.60)

 Conformity Index (opt =1)

1.00

(0.39)

 CO (opt =1)

0.93

(0.03)

 HI (opt = 0)

0.12

(0.13)

Planning Target Volume 2

  

 Dose, Gy

60.36

(2.92)

 Conformity Index (opt =1)

0.57

(0.39)

 CO

0.96

(0.03)

 HI

0.07

(0.14)

  1. SD, standard deviation
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us